Ignite Creation Date:
2025-12-24 @ 9:08 PM
Ignite Modification Date:
2026-01-02 @ 9:44 AM
Study NCT ID:
NCT05051904
Status:
COMPLETED
Last Update Posted:
2024-03-07
First Post:
2021-09-15
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
A Study Based on Japanese Medical Records That Looks at Bleeding Events in People With Atrial Fibrillation and Coronary Artery Disease Who Start Taking Either Dabigatran, Rivaroxaban, or Warfarin
Sponsor:
Boehringer Ingelheim
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-05-17
Start Date Type:
ACTUAL
Primary Completion Date:
2022-07-29
Primary Completion Date Type:
ACTUAL
Completion Date:
2022-07-29
Completion Date Type:
ACTUAL
First Submit Date:
2021-09-15
First Submit QC Date:
None
Study First Post Date:
2021-09-21
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2023-07-26
Results First Submit QC Date:
None
Results First Post Date:
2024-03-07
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2023-07-26
Last Update Post Date:
2024-03-07
Last Update Post Date Type:
ACTUAL